NCI’s investments in cancer control, population health, and survivorship are aimed at reducing cancer risk, incidence, and mortality and on improving the quality of life of cancer survivors and the general population.
This schematic shows the steps for creating CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.
There are hundreds of clinical trials underway studying CAR T-cell therapy, a type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells.
Information mapped in human tumor atlases will provide a comprehensive understanding of the ecosystem of tumors and show important transitions in cancer.
As has been true for many years, NCI continues to support a broad portfolio of research aimed at improving the early detection and diagnosis of cancer and its precursors.
NCI’s mission is to lead, conduct, and support cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives.
The NCI Method to Extend Research in Time (MERIT) (R37) Award provides longer term grant support to early stage investigators. This graph shows that R01 awards provide 5 years of funding versus R37 awards, which provide 7 years of funding.
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
Dr. Ned Sharpless, director of the National Cancer Institute, has discussed four key focus areas for NCI: growing the workforce, pursuing more basic science, using Big Data, and modernizing clinical trials.
Dr. Ned Sharpless, director of the National Cancer Institute, with Mike, a patient he treated for acute leukemia. Cancer patients like Mike are NCI's true partners in cancer research.
